Your browser doesn't support javascript.
loading
Poly (ADP-ribose) polymerase inhibitors (PARPi) for advanced malignancies with multiple DNA-repair genetic aberrations.
Hu, Jian; Liang, Peihe; Jin, Dachun; Fan, Runze; Xie, Xiaodu; Liu, Chuan; Jiang, Qing; Gao, Liang.
Afiliação
  • Hu J; Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chong Qing, China.
  • Liang P; Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chong Qing, China.
  • Jin D; Department of Urology, Daping Hospital/Army Medical Center of PLA, Army Medical University.
  • Fan R; Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chong Qing, China.
  • Xie X; Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chong Qing, China.
  • Liu C; Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chong Qing, China.
  • Jiang Q; Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chong Qing, China.
  • Gao L; Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chong Qing, China.
Expert Rev Anticancer Ther ; 22(7): 717-723, 2022 07.
Article em En | MEDLINE | ID: mdl-35679134

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Poli(ADP-Ribose) Polimerases / Neoplasias Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Poli(ADP-Ribose) Polimerases / Neoplasias Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article